The ageing population, coupled with the increasing cases of cardiovascular diseases, and advancement in new innovative technologies, are driving the growth of Implantable Cardioverter Defibrillator (ICD) devices. ICDs are widely being used in Americas and Europe. Further, expansion of ICD therapies across the different Asian countries like China, Japan and India holds a potential growth for the ICD market.

Consolidation of the industry through acquisitions and partnerships is also contributing to the growth of the ICD market in the industry. Over the past years, several large competitors have made significant acquisitions to fast-track technology into the market.

The market for ICD shows a potential growth due to the increasing number of cardio vascular diseases (due to factors such as smoking, obesity, etc). The awareness of risk of developing cardiovascular problems and availability of the required treatment has enabled access to new technologies and quality products. This results in increase in the number of implants, and favorably influences the market growth.

The report forecasts the size of the global implantable cardioverter defibrillator (ICD) over the period 2008-2012. It segments the market into three geographic regions: Americas, APAC and EMEA, representing the market size and forecast for each of these regions. Further, it discusses the key market trends, drivers and challenges of the global implantable cardioverter defibrillator market and profiles some of the key vendors of this industry.